Difference between revisions of "Editorial Board"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
Warner-admin (talk | contribs) m (Text replacement - "#3182bd" to "#08519c") |
||
Line 19: | Line 19: | ||
=Section Editors= | =Section Editors= | ||
{| class="wikitable" style="text-align:center; width:100%;" | {| class="wikitable" style="text-align:center; width:100%;" | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Dermatologic Oncology''' |
|- | |- | ||
|rowspan=4 style="background-color:#F0F0F0; width:25%;"|[[File:Bethbuchbinder.jpg|frameless|upright=0.4|center]] | |rowspan=4 style="background-color:#F0F0F0; width:25%;"|[[File:Bethbuchbinder.jpg|frameless|upright=0.4|center]] | ||
Line 31: | Line 31: | ||
|style="background-color:#deebf7"|[[Squamous cell carcinoma (SCC)]] | |style="background-color:#deebf7"|[[Squamous cell carcinoma (SCC)]] | ||
|- | |- | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Gastrointestinal Oncology''' |
|- | |- | ||
|rowspan=11 style="background-color:#F0F0F0"|[[File:nkv.jpg|frameless|upright=0.4|center]] | |rowspan=11 style="background-color:#F0F0F0"|[[File:nkv.jpg|frameless|upright=0.4|center]] | ||
Line 57: | Line 57: | ||
|style="background-color:#deebf7"|[[Rectal cancer]] | |style="background-color:#deebf7"|[[Rectal cancer]] | ||
|- | |- | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Genitourinary Oncology''' |
|- | |- | ||
|rowspan=5 style="background-color:#F0F0F0"|[[File:aymen_elfiky.jpg|frameless|upright=0.4|center]] | |rowspan=5 style="background-color:#F0F0F0"|[[File:aymen_elfiky.jpg|frameless|upright=0.4|center]] | ||
Line 71: | Line 71: | ||
|style="background-color:#deebf7"|[[Testicular cancer]] | |style="background-color:#deebf7"|[[Testicular cancer]] | ||
|- | |- | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Gynecologic Oncology''' |
|- | |- | ||
|rowspan=3 style="background-color:#F0F0F0"|[[File:BrandonSeagle.jpg|frameless|upright=0.4|center]] | |rowspan=3 style="background-color:#F0F0F0"|[[File:BrandonSeagle.jpg|frameless|upright=0.4|center]] | ||
Line 81: | Line 81: | ||
|style="background-color:#deebf7"|[[Uterine cancer]] | |style="background-color:#deebf7"|[[Uterine cancer]] | ||
|- | |- | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Head & Neck Cancer''' |
|- | |- | ||
|rowspan=3 style="background-color:#F0F0F0"|[[File:Michaelgibson.jpg|frameless|upright=0.4|center]] | |rowspan=3 style="background-color:#F0F0F0"|[[File:Michaelgibson.jpg|frameless|upright=0.4|center]] | ||
Line 91: | Line 91: | ||
|style="background-color:#deebf7"|[[Thyroid cancer]] | |style="background-color:#deebf7"|[[Thyroid cancer]] | ||
|- | |- | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Neuro-Oncology''' |
|- | |- | ||
|rowspan=6 style="background-color:#F0F0F0"|[[File:SeemaNagpal.jpg|frameless|upright=0.4|center]] | |rowspan=6 style="background-color:#F0F0F0"|[[File:SeemaNagpal.jpg|frameless|upright=0.4|center]] | ||
Line 107: | Line 107: | ||
|style="background-color:#deebf7"|[[Meningioma]] | |style="background-color:#deebf7"|[[Meningioma]] | ||
|- | |- | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Sarcoma''' |
|- | |- | ||
|rowspan=6 style="background-color:#F0F0F0"|[[File:jim_chen.jpeg|frameless|upright=0.4|center]] | |rowspan=6 style="background-color:#F0F0F0"|[[File:jim_chen.jpeg|frameless|upright=0.4|center]] | ||
Line 123: | Line 123: | ||
|style="background-color:#deebf7"|[[Vascular sarcoma]] | |style="background-color:#deebf7"|[[Vascular sarcoma]] | ||
|- | |- | ||
− | !colspan="3" align="center" style="color:white; font-size:125%; background-color:# | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Thoracic Oncology''' |
|- | |- | ||
|rowspan=5 style="background-color:#F0F0F0"|[[File:TravisOsterman.jpg|frameless|upright=0.4|center]] | |rowspan=5 style="background-color:#F0F0F0"|[[File:TravisOsterman.jpg|frameless|upright=0.4|center]] |
Revision as of 02:33, 14 January 2018
We have recently appointed an editorial board of clinical experts, organized primarily by disease focus. Many disease sites now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Editor-in-Chief
Peter C. Yang, MD Boston, MA Twitter: Hem_Onc |
Deputy Editor
Jeremy L. Warner, MD, MS Nashville, TN Twitter: Hemoncwarner |